Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

CLASS-ACTION SUIT AGAINST XYTRONYX

Feb. 6, 1992

GENETIC REGIONS THAT CAUSE MD

Feb. 6, 1992

IMMUNOMEDICS GETS SBIR

Feb. 6, 1992

VCS OPTIMISTIC ABOUT 1992

Feb. 6, 1992

METRA RAISES $6 MILLION IN FINANCING

Feb. 6, 1992

ECOSCIENCE RAISES $28.6 MILLION IN IPO

Feb. 6, 1992

VESTAR OFFERING RAISES $50 MILLION

Feb. 6, 1992

ENCOURAGING DATA FROM IMMUNEX TRIALS

Feb. 6, 1992

ANALYSTS QUESTION U.S. BIO STOCK TRADING

Feb. 5, 1992

UNIVAX IPO RAKES IN $48 MILLION

Feb. 5, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...